Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue Kallikrein for MCA Restenosis Prevention (KPRASS)
NCT01558245Phase 2Unknown
- Sponsor
- Jinling Hospital
- Start
- Dec 2011
- Primary completion
- Dec 2013
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Human urinary kallidinogenase in middle cerebral artery stenosis (MCAS), sponsored by Jinling Hospital. Status: unknown.
02
Drugs
Human urinary kallidinogenase
03
Conditions
middle cerebral artery stenosis (MCAS)
Beyond the preview
Go deeper on NCT01558245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558245.